TCTR20170623004已完成2 期
Efficacy and tolerability of two quadruple regimens;bismuth,omeprazole, metronidazole and Amoxicillin or tetracycline as first line treatment for eradication of helicobacter pylori in patients with duodenal ulcer
Shahid Sadoughi University of Medical Sciences0 个研究点目标入组 228 人开始时间: 2017年6月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 228
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Patients were eligible if they were aged
- •18 years or older and had confirmed H pylori infection. H
- •pylori infection was diagnosed by either a positive rapid urease
- •test or positive identification of H pylori in a histological sample
- •using haematoxylin and eosin and/or Giemsa stain
排除标准
- •were excluded if they had any of the followings: previous eradication
- •therapy for H pylori; known allergies to any of the study
- •medications; recent use of antibiotics, bismuth salts, probiotic
- •preparations, proton pump inhibitors or non-steroidal antiinflammatory
- •drugs in the preceding 1 month; pregnant or lactating
- •women; previous gastric surgery; alcohol or drug abuse;
- •or severe concurrent medical illnesses, such as liver failure, renal
- •failure or terminal malignancy
研究者
相似试验
已完成
1 期
A comparison between triple and quadruple therapy efficacy in eradication of Helicobacter pylori in patients with dyspepsiaHelicobacter Pylori.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersIRCT2016012623736N2orestan University of Medical Sciences321
招募中
4 期
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori EradicationHELICOBACTER PYLORI INFECTIONSNCT06723197Shandong University330
已完成
4 期
Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in EgyptiansH.Pylori InfectionNCT06315478Helwan University60
尚未招募
2 期
Investigating the effect of furazolidone drug for the treatment of stomach bacterial infectioH. pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81IRCT20230202057305N1Shahid Beheshti University of Medical Sciences135
已完成
1 期
Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202Parkinson's DiseaseNCT02772627Bial - Portela C S.A.22